From: Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer
Names of drugs
Enrichment
p value
n
Percent non-null
flurbiprofen
-0.947
0.00026
3
100%
meclozine
-0.911
0.00124
alfuzosin
-0.894
0.00226
ethotoin
-0.893
0.00234
fenoprofen
-0.848
0.00699